WT1 mutations or inactivation have been implicated in the leukemogenesis of AML.30 The correlation between WT1 and MEG3 expression in clinical samples and AML cell lines therefore led us to hypothesize that the WT1 transcription factor regulates MEG3 expression. The gene discussed is MEG3; the disease is acute myeloid leukemia.